The US Chinese Anti-Cancer Association and the National Foundation for Cancer Research recognize five young Chinese investigators with the 2014 USCACA-NFCR Scholar Awards

Abstract

To facilitate and strengthen collaborations among cancer researchers and physicians in the United States and China, the US Chinese Anti-Cancer Association (USCACA) and the National Foundation for Cancer Research (NFCR) have established the Scholar Excellence Award for the USCACA-NFCR Scholar Exchange and Fellowship Program in Basic, Translational, and Clinical Studies. From 2010 to 2013, 14 young Chinese researchers and physicians have been recognized by the award for their outstanding achievements in cancer research accomplished both during their training in the United States and after their returning to China[1]–[3]. This year, 5 young scientists were selected on the basis of their significant contributions in translational cancer research. Here, we are proud to present these outstanding winners of the 2014 USCACA-NFCR Scholar Award: Dr. Yan Cheng, School of Pharmaceutical Sciences, Central South University, Changsha; Dr. Guoyan Liu, Department of Gynecology and Obstetrics, Tianjin Medical University General Hospital, Tianjin; Dr. Fengju Song, Department of Epidemiology, Tianjin Medical University Cancer Institute and Hospital, Tianjin; Dr. Yanxia Shi, Sun Yat-sen University Cancer Center, Guangzhou; Dr. Suling Liu, School of Life Sciences, University of Science and Technology of China, Hefei. The USCACA and NFCR presented the award to these 5 awardees during the 17th Annual Meeting of the Chinese Society of Clinical Oncology (CSCO) held in Xiamen, September 17-21, 2014. The ceremony of the 5th USCACA-NFCR Scholar Excellent Award was held at Sheraton Xiamen on September 19, 2014. The 5 winners were invited to contribute a brief summary introducing their academic background, highlighting their achieve-ments in cancer research, and outlining their current research plans in China. All awardees have received excellent postdoctoral training under their US mentors who are active cancer researchers and USCACA members. The discoveries and findings from these talented young scientists have not only significantly improved our understanding of the mechanisms underlying the causes or progression of human cancers but also shed light on novel approaches to improve treatment and care for cancer patients. Our ultimate goal is to conquer cancer by encouraging the translation of experimental findings into novel cancer therapies, fostering collaborations in clinical cancer drug development, and sharing expert knowledge and medical practices between China and the United States.